Daxor Corporation (NASDAQ: DXR)
$9.02
-0.1800 ( -1.96% ) 0.2K
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Market Data
Open
$9.02
Previous close
$9.20
Volume
0.2K
Market cap
$44.50M
Day range
$8.91 - $9.31
52 week range
$7.11 - $10.15
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Nov 13, 2023 |
4 | Insider transactions | 1 | Nov 02, 2023 |
8-k | 8K-related | 12 | Oct 27, 2023 |
4 | Insider transactions | 1 | Oct 16, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
n-csrs | Other | 3 | Aug 28, 2023 |
n-px | Other | 1 | Aug 15, 2023 |
4 | Insider transactions | 1 | Jul 13, 2023 |
4 | Insider transactions | 1 | Jul 13, 2023 |
4 | Insider transactions | 1 | Jul 13, 2023 |